Takeda Pharmaceutical

Takeda Pharmaceutical

Pharmaceuticals
Takeda Pharmaceutical is Japan’s largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company’s five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.

$69.1B

Market Cap • 11/17/2026

1925

(101 years)

Founded

2008

(18 years ago)

IPO

NYSE

Listing Exchange

Flag of Japan

Japan

Country

Valuation

P/B

1,5

P/S

2,3

P/EBITDA

9

P/OCF

13,1

P/FCF

16,6

P/E

292,8

BVPS

14,7

EPS

0,8

Market Cap

Market Cap

69,1B

EV

95,3B

EV/Revenue

3,2

EV/EBITDA

12,4

EV/EBIT

27

Payout

Dividend Per Share

0,6

Dividend Yield

2,9%

Buyback Yield

0%

Total Yield

2,9%

Dividend Yield 5Y

4%

Payout

79,5%

Retained Earnings

5,5B

Profitability

Gross Margin

65,8%

EBITDA Margin

26%

EBIT Margin

12%

Net Margin

8,2%

D&A/EBITDA

37,8%

R&D/Revenue

15,1%

Capex/Revenue

3,9%

Capex/D&A

27,5%

Capex/OCF

21,5%

SBC/OCF

8,7%

% PPE

14,9%

% Goodwill

37,2%

ROE

5,1%

ROIC

4,2%

Growth

CAGR Revenue 5Y

0%

CAGR Op. Income 5Y

-8,9%

CAGR Net Income 5Y

-10,4%

CAGR EPS 5Y

-44,3%

CAGR OCF 5Y

-10,1%

Leverage

N.D./EBITDA

3,4

Debt/Equity

0%

Current Ratio

1,2

Quick Ratio

0,5

Interest Coverage

165,1%

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium